Physician

Lynn Clark Vanwagnen, MD

According to 2025 Medicare claims, Lynn Vanwagnen, MD (NPI: 1609833359) practices internal medicine in the Jackson, MI market, with the plurality of this provider's patient population coming from Jackson, MI. This provider's primary affiliated billing organization is LYNN VAN WAGNEN MD PC (NPI: 1396973129; TIN: 382518782) and primary practice location at 49203-3077. Vanwagnen is affiliated with the Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Vanwagnen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 327 traditional Medicare patients, billed 2,183 HCPCS/CPT codes, and received $117,507 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 10,654 prescription claims across 511 beneficiaries totaling $1,108,889 in drug costs, led by Eliquis (Apixaban). DME data shows 409 claims. Open Payments data shows 14 records totaling $281. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $251,688 to $117,507. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $22,533 to $24,441.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	591	5,303	$251,688
2016	622	4,978	$232,418
2017	810	4,236	$199,027
2018	653	3,890	$197,290
2019	632	3,854	$203,720
2020	474	2,876	$143,607
2021	465	2,643	$153,595
2022	400	2,147	$131,268
2023	367	2,028	$124,068
2024	327	2,183	$117,507

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	543	11,425	$889,918
2016	512	10,865	$844,073
2017	534	10,455	$794,379
2018	568	10,367	$934,788
2019	555	10,377	$940,991
2020	534	10,232	$974,000
2021	538	10,145	$990,528
2022	527	9,981	$1,016,503
2023	504	10,612	$1,161,154
2024	511	10,654	$1,108,889

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	197	484	$12,806
2016	163	426	$10,565
2017	158	415	$7,855
2018	197	513	$11,920
2019	214	506	$9,991
2020	202	486	$13,910
2021	200	481	$15,397
2022	149	514	$21,683
2023	169	527	$26,575
2024	155	409	$22,994

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	140	140	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	139	290	$85
90653	Influenza vaccine, inactivated	115	115	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	223	671	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	173	394	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	202	13,100	$243,256
Trulicity	Dulaglutide	95	4,032	$133,525
Xarelto	Rivaroxaban	103	6,120	$111,864
Ozempic	Semaglutide	83	3,304	$105,916
Jardiance	Empagliflozin	93	4,558	$88,643

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	30	$12,847
A7030	Full face mask used with positive airway pressure device, each	N	24	45	$3,413
A7031	Face mask interface, replacement for full face mask, each	N	16	38	$1,888
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	14	28	$902
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	23	$673

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$281	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Lynn Clark Vanwagnen, MD?

Tedicare shows public-source Medicare data for Lynn Clark Vanwagnen, MD (NPI 1609833359), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lynn Clark Vanwagnen, MD have ACO affiliation data?

Lynn Clark Vanwagnen, MD is shown with ACO affiliation data for Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Lynn Clark Vanwagnen, MD?

Lynn Clark Vanwagnen, MD is linked to LYNN VAN WAGNEN MD PC (billing NPI 1396973129) in the available physician profile data.

Does Lynn Clark Vanwagnen, MD have Open Payments data?

Lynn Clark Vanwagnen, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.